gaps – Pharma GMP

How to Use a GMP Checklist to Prepare for Inspections in OSD Plants

digi — Wed, 26 Nov 2025 04:21:04 +0000

How to Use a GMP Checklist to Prepare for Inspections in OSD Plants Step-by-Step Guide: Using a GMP Checklist for Oral Solid Dosage Manufacturing Inspection Preparation Preparing an Oral Solid Dosage (OSD) manufacturing facility for regulatory inspections requires meticulous planning, comprehensive documentation, and rigorous adherence to Good Manufacturing Practice (GMP). A GMP checklist for oral...

Top Line Clearance Checklist Gaps Found in FDA 483s

digi — Wed, 26 Nov 2025 01:39:04 +0000

Top Line Clearance Checklist Gaps Found in FDA 483s Effective Line Clearance Checklist for Production: Addressing Common Gaps Cited in FDA 483 Observations The line clearance process represents a critical step within pharmaceutical manufacturing, ensuring cleanliness, correct materials, and proper documentation before initiating each production batch. Regulatory inspectors from agencies like the FDA frequently cite...

Inspection Experiences: Environmental Monitoring Gaps in QC Laboratories

digi — Tue, 25 Nov 2025 13:09:04 +0000

Inspection Experiences: Environmental Monitoring Gaps in QC Laboratories How to Identify and Address Environmental Monitoring Gaps in QC Laboratories: A Step-by-Step Tutorial The environmental monitoring program for QC laboratories is a critical component of pharmaceutical Good Manufacturing Practice (GMP) compliance. Regulatory authorities across the US, UK, and EU, including the FDA, EMA, MHRA, and PIC/S,...

Inspection Focus on Control of Intermediates in Warehouse Areas

digi — Tue, 25 Nov 2025 09:06:04 +0000

Inspection Focus on Control of Intermediates in Warehouse Areas Step-by-Step Guide to Effective Quarantine and Release Procedure for Intermediates in Pharmaceutical Warehouses The control of pharmaceutical intermediates stored in warehouse areas is a critical regulatory expectation enforced by authorities such as the FDA, EMA, and MHRA. Ensuring rigorous quarantine and release procedures for intermediates prevents...

Investigating Material Traceability Gaps and Data Integrity Concerns

digi — Tue, 25 Nov 2025 08:33:04 +0000

Investigating Material Traceability Gaps and Data Integrity Concerns Step-by-Step Guide to Investigating Material Movement Traceability Gaps and Data Integrity in GMP Facilities Ensuring robust material movement traceability in GMP facilities is a fundamental pillar of pharmaceutical quality assurance, encompassing manufacturing, quality control, and supply chain management. Traceability allows for full accountability regarding the status, location,...

Audit Observations on Weak Stock Verification and Inventory Control

digi — Tue, 25 Nov 2025 08:06:04 +0000

Audit Observations on Weak Stock Verification and Inventory Control Step-by-Step Tutorial on Strengthening Periodic Stock Verification Procedure in GMP Maintaining robust inventory control and periodic stock verification procedure in GMP environments is a critical pillar of pharmaceutical warehouse and material management. In pharmaceutical manufacturing and distribution, weak stock verification controls can result in audit findings...

Audit Observations on Poor Environmental Monitoring in Warehouse Facilities

digi — Tue, 25 Nov 2025 07:42:04 +0000

Audit Observations on Poor Environmental Monitoring in Warehouse Facilities Addressing Audit Observations on Environmental Monitoring in Warehouse Areas: A Step-by-Step GMP Tutorial Environmental monitoring in warehouse areas is a critical component of Good Manufacturing Practice (GMP) compliance in pharmaceutical manufacturing, storage, and distribution. Warehouse environments must be controlled and monitored to ensure the quality, safety,...

Audit Findings Linked to Poor Use of Cleaning Checklists

digi — Tue, 25 Nov 2025 00:03:42 +0000

Audit Findings Linked to Poor Use of Cleaning Checklists Improving Compliance Through Effective GMP Cleaning Checklists for Production Equipment Within pharmaceutical manufacturing environments governed by stringent regulatory frameworks such as FDA 21 CFR Parts 210 and 211, EU GMP Volume 4 including Annex 15, and PIC/S GMP guidelines, the cleaning of production equipment is an...

Top 10 Line Clearance Checklist Gaps Found in FDA 483s

digi — Mon, 24 Nov 2025 20:27:42 +0000

Top 10 Line Clearance Checklist Gaps Found in FDA 483s Step-by-Step Guide to Address the Top 10 Line Clearance Checklist Gaps Found in FDA 483s Line clearance is a critical component of pharmaceutical Good Manufacturing Practice (GMP) compliance, aimed at preventing cross-contamination and mix-ups during production. Regulatory agencies such as the FDA frequently identify deficiencies...